1.
Bioorg Med Chem Lett
; 13(8): 1483-6, 2003 Apr 17.
Artigo
em Inglês
| MEDLINE
| ID: mdl-12668017
RESUMO
In our continuing efforts to identify small molecule vitronectin receptor antagonists, we have discovered a series of phenylbutyrate derivatives, exemplified by 16, which have good potency and excellent oral bioavailability (approximately 100% in rats). This new series is derived conceptually from opening of the seven-membered ring of SB-265123.